June 2016

The June meeting’s  program was a video on Immune Therapy from the Prostate Cancer Research Institute, which included important information on clinical trials and treatments coming along the pipeline for prostate cancer.

High-Risk PCa: Start With Radiation, ADT?
by Gerald Chodak, MD
May 23, 2016

A Treatment Vaccine for Low-Risk Prostate Cancer
by Neil Osterweil
May 20, 2016

Short-Term Androgen Suppression Benefits Men After Prostatectomy
by Marilynn Larkin
May 18, 2016

Immediate ADT Improves Survival in Relapsed Prostate Cancer
by Roxanne Nelson BSN, RN
May 11, 2016

Prostate Screening ‘Wrongfully Convicted’: PLCO Reanalysis
by Kate Johnson
May 11, 2016

Prostate Cancer: ‘Active’ Surveillance Is Often ‘Not’
by Kate Johnson
May 09, 2016

Active Surveillance for PCa: Popular but Not Perfect
by Gerald Chodak, MD
May 05, 2016

Some Elderly Men Get Prostate Cancer Tests Despite Limited Benefit
by Lisa Rapaport
May 05, 2016

USPSTF Re-evaluates PSA Testing; Here’s Their Plan
by Nick Mulcahy
May 04, 2016

African-American Men Experience More Aggressive Prostate Cancer
by Will Boggs MD
May 04, 2016

Patient QoL: More Proof That PCa Surveillance Is a ‘Reasonable Approach’
by Gerald Chodak, MD
April 26, 2016

Urology Times
Greater long-term side effect risk with intermittent ADT
by Wayne Kuznar
May 01, 2016

Experimental prostate Ca urinary test outperforms PSA
by Lisette Hilton
April 28, 2016

Cancer Network
Cancer Diagnosis Linked With Increased Risk of Mental Disorders
by Dave Levitan
April 28, 2016

Maintaining High Physical Activity Improves Prostate Cancer Survival
by Anna Azvolinsky
April 19, 2016


*a free, one-time registration is required in order to view the entire article and all other content on the Medscape sites. If you do not wish to create your own free account, you may log in with username psalawrence and password jayhawk.